Register Login

ANAPTYSBIO, INC (ANAB)

SymbolANAB
NameANAPTYSBIO, INC
SectorHEALTH CARE
RegionNorth America
IndustryPharmaceutical Preparations
Address10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA 92121
Telephone858-362-6295
Fax—
Email—
Websitehttps://www.anaptysbio.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001370053
Description

AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements.

Additional info from NASDAQ:
AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements.

2026-09-01 20:15

Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference

Read more
2026-08-14 09:31

New Form SCHEDULE 13G/A - ANAPTYSBIO, INC <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005200 <b>Size:</b> 10 KB

Read more
2026-08-11 20:05

(99% Neutral) ANAPTYSBIO, INC (ANAB) Announces Regulatory Update

Read more
2026-08-07 21:13

Lizzul Paul F. 🟢 acquired 16.7K shares (1 derivative) of ANAPTYSBIO, INC (ANAB) Transaction Date: Mar 12, 2026 | Filing ID: 000012

Read more
2026-08-07 21:12

Faga Daniel 🟢 acquired 53.3K shares (1 derivative) of ANAPTYSBIO, INC (ANAB) Transaction Date: Mar 12, 2026 | Filing ID: 000016

Read more
2026-06-29 20:15

📋 DENNIS MULROY (Officer) plans to sell 9K shares of ANAPTYSBIO, INC. (at $63.45 each, total $601K) Filed: Jun 29, 2026 | ID: 006580

Read more
2026-06-29 17:09

New Form ARS - ANAPTYSBIO, INC <b>Filed:</b> 2026-06-29 <b>AccNo:</b> 0001193125-26-288436 <b>Size:</b> 4 MB

Read more
2026-06-26 20:46

📋 DENNIS MULROY (Officer) plans to sell 10K shares of ANAPTYSBIO, INC. (at $60.82 each, total $608K) Filed: Jun 26, 2026 | ID: 006565

Read more
2026-06-22 20:05

(99% Neutral) ANAPTYSBIO, INC (ANAB) Announces Business Combination

Read more
2026-06-17 20:29

📋 DENNIS MULROY (Officer) plans to sell 850 shares of ANAPTYSBIO, INC. (at $60.00 each, total $51K) Filed: Jun 17, 2026 | ID: 006265

Read more